Ara-290
Ara-290
$ 48
A non-erythropoietic peptide analogue of erythropoietin (EPO) that targets the innate repair receptor (IRR) without stimulating red blood cell production. Used for neuropathic pain, small fiber neuropathy, sarcoidosis, and metabolic syndrome. Strong anti-inflammatory and tissue- protective effects.
Benefits
✓ Neuropathic pain relief (small fiber neuropathy)
✓ Anti-inflammatory signaling via IRR
✓ Tissue protection and repair
✓ Metabolic improvement (insulin resistance, beta-cell protection)
✓ Sarcoidosis-related neuropathy treatment
✓ No erythropoietic (blood-doping) effect
✓ Anti-inflammatory signaling via IRR
✓ Tissue protection and repair
✓ Metabolic improvement (insulin resistance, beta-cell protection)
✓ Sarcoidosis-related neuropathy treatment
✓ No erythropoietic (blood-doping) effect
Side Effects
• Injection site reactions
• Mild dizziness
• Headache
• Fatigue (rare)
• Generally very well tolerated in clinical trials
• Limited long-term data
• Mild dizziness
• Headache
• Fatigue (rare)
• Generally very well tolerated in clinical trials
• Limited long-term data
Half Life
4 hours
Note
Ara-290
$ 48
A non-erythropoietic peptide analogue of erythropoietin (EPO) that targets the innate repair receptor (IRR) without stimulating red blood cell production. Used for neuropathic pain, small fiber neuropathy, sarcoidosis, and metabolic syndrome. Strong anti-inflammatory and tissue- protective effects.
✓ Neuropathic pain relief (small fiber neuropathy)
✓ Anti-inflammatory signaling via IRR
✓ Tissue protection and repair
✓ Metabolic improvement (insulin resistance, beta-cell protection)
✓ Sarcoidosis-related neuropathy treatment
✓ No erythropoietic (blood-doping) effect
✓ Anti-inflammatory signaling via IRR
✓ Tissue protection and repair
✓ Metabolic improvement (insulin resistance, beta-cell protection)
✓ Sarcoidosis-related neuropathy treatment
✓ No erythropoietic (blood-doping) effect
4 hours
